Overview and Scope
Visceral pain refers to the pain that originates from the internal organs, such as the stomach, bladder, uterus, or rectum. Visceral pain can be caused by various factors, including inflammation, menstrual cramps, swelling and stretching of the organs, blockage, decreased blood flow, and tumors, especially when concentrated in the pelvis or abdomen. It is commonly associated with additional symptoms such as nausea, perspiration, or an accelerated heartbeat.
Sizing and Forecast
The visceral pain treatment market size has grown strongly in recent years. It will grow from $12.87 billion in 2023 to $13.84 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to aging population, increased incidence of chronic diseases, advances in medical research, expansion of healthcare infrastructure, rising awareness and diagnosis rates.
To access more details regarding this report, visit the link
https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report
Segmentation & Regional Insights
The visceral pain market covered in this report is segmented –
1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes
2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications
3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users
North America was the largest region in the visceral pain market in 2023. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp
Major Driver Impacting Market Growth
The rising demand for analgesics is expected to fuel the growth of the visceral pain market going forward. Analgesics refer to medications that alleviate pain by diminishing or blocking the perception of pain signals in the brain. Analgesics help manage visceral pain by targeting the nervous system and modulating pain signals originating from internal organs. For instance, in December 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based, science-based, data-driven organization that protects public health in the United States, meticulously documented, a total number of dispensed Buprenorphine (an opioid analgesic) prescriptions saw a notable increase from 16,011,239 in 2020 to 16,105,318 in 2021, which represents a notable 0.59% increase when contrasted with the corresponding period in 2020. Therefore, the rising demand for analgesics is driving the growth of the visceral pain market.
Key Industry Players
Major companies operating in the visceral pain market report are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd., , , , , ,
The visceral pain market report table of contents includes:
1. Executive Summary
2. Visceral Pain Market Characteristics
3. Visceral Pain Market Trends And Strategies
4. Visceral Pain Market – Macro Economic Scenario
5. Global Visceral Pain Market Size and Growth
…………………………..
32. Global Visceral Pain Market Competitive Benchmarking
33. Global Visceral Pain Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Visceral Pain Market
35. Visceral Pain Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
